vs
Side-by-side financial comparison of AlTi Global, Inc. (ALTI) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
AlTi Global, Inc. is the larger business by last-quarter revenue ($86.6M vs $47.7M, roughly 1.8× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -15.1%, a 10.4% gap on every dollar of revenue. On growth, AlTi Global, Inc. posted the faster year-over-year revenue change (87.0% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-52.2M). Over the past eight quarters, AlTi Global, Inc.'s revenue compounded faster (30.6% CAGR vs -20.2%).
Cristal Global is the world's second-largest producer of titanium dioxide and a leading producer of titanium chemicals. It was formed when The National Titanium Dioxide Company Ltd. combined with Millennium Chemicals. The headquarters are in Jeddah, Saudi Arabia. It is a significant shareholder in Bemax, the world’s 5th largest TiO2 feedstock producer.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
ALTI vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.6M | $47.7M |
| Net Profit | $-13.1M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | -2.1% | 14.3% |
| Net Margin | -15.1% | -4.8% |
| Revenue YoY | 87.0% | -47.3% |
| Net Profit YoY | 75.6% | -200.9% |
| EPS (diluted) | — | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.6M | $47.7M | ||
| Q3 25 | $57.2M | $122.1M | ||
| Q2 25 | $53.1M | $85.2M | ||
| Q1 25 | $58.0M | $41.1M | ||
| Q4 24 | $46.3M | $90.5M | ||
| Q3 24 | $51.8M | $91.6M | ||
| Q2 24 | $49.5M | $94.4M | ||
| Q1 24 | $50.8M | $74.9M |
| Q4 25 | $-13.1M | $-2.3M | ||
| Q3 25 | $-84.1M | $40.1M | ||
| Q2 25 | $-24.4M | $23.6M | ||
| Q1 25 | $1.9M | $-37.4M | ||
| Q4 24 | $-53.8M | $2.3M | ||
| Q3 24 | $-72.5M | $3.6M | ||
| Q2 24 | $-6.4M | $-860.0K | ||
| Q1 24 | $29.7M | $-4.2M |
| Q4 25 | -2.1% | 14.3% | ||
| Q3 25 | -49.8% | 61.8% | ||
| Q2 25 | -56.7% | 53.2% | ||
| Q1 25 | -23.3% | -70.7% | ||
| Q4 24 | -42.7% | 34.8% | ||
| Q3 24 | -18.4% | 28.0% | ||
| Q2 24 | -30.2% | 26.5% | ||
| Q1 24 | -28.9% | 14.7% |
| Q4 25 | -15.1% | -4.8% | ||
| Q3 25 | -147.0% | 32.8% | ||
| Q2 25 | -45.9% | 27.7% | ||
| Q1 25 | 3.3% | -90.9% | ||
| Q4 24 | -116.1% | 2.5% | ||
| Q3 24 | -140.0% | 4.0% | ||
| Q2 24 | -12.9% | -0.9% | ||
| Q1 24 | 58.4% | -5.6% |
| Q4 25 | — | $0.01 | ||
| Q3 25 | — | $0.23 | ||
| Q2 25 | $-0.33 | $0.14 | ||
| Q1 25 | $-0.04 | $-0.23 | ||
| Q4 24 | $-0.71 | $0.03 | ||
| Q3 24 | $-0.88 | $0.02 | ||
| Q2 24 | $-0.18 | $-0.01 | ||
| Q1 24 | $0.18 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.2M | $215.5M |
| Total DebtLower is stronger | $883.0K | — |
| Stockholders' EquityBook value | $600.1M | $-261.8M |
| Total Assets | $1.2B | $396.9M |
| Debt / EquityLower = less leverage | 0.00× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $41.2M | $215.5M | ||
| Q3 25 | $35.8M | $140.4M | ||
| Q2 25 | $42.4M | $92.9M | ||
| Q1 25 | $52.8M | $108.5M | ||
| Q4 24 | $64.4M | $88.6M | ||
| Q3 24 | $220.6M | $88.2M | ||
| Q2 24 | $60.0M | $105.5M | ||
| Q1 24 | $134.2M | $121.5M |
| Q4 25 | $883.0K | — | ||
| Q3 25 | $586.0K | $199.5M | ||
| Q2 25 | $673.0K | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | $0 | $199.0M | ||
| Q3 24 | $128.4M | $198.8M | ||
| Q2 24 | $164.0M | $198.6M | ||
| Q1 24 | $183.7M | $398.3M |
| Q4 25 | $600.1M | $-261.8M | ||
| Q3 25 | $607.2M | $-264.2M | ||
| Q2 25 | $685.4M | $-308.2M | ||
| Q1 25 | $665.2M | $-334.1M | ||
| Q4 24 | $658.4M | $-301.3M | ||
| Q3 24 | $707.0M | $-311.3M | ||
| Q2 24 | $540.2M | $-321.7M | ||
| Q1 24 | $510.9M | $-330.5M |
| Q4 25 | $1.2B | $396.9M | ||
| Q3 25 | $1.2B | $396.1M | ||
| Q2 25 | $1.2B | $342.9M | ||
| Q1 25 | $1.2B | $327.2M | ||
| Q4 24 | $1.3B | $350.9M | ||
| Q3 24 | $1.4B | $389.5M | ||
| Q2 24 | $1.3B | $395.6M | ||
| Q1 24 | $1.3B | $438.8M |
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.30× | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-51.4M | $74.6M |
| Free Cash FlowOCF − Capex | $-52.2M | $74.6M |
| FCF MarginFCF / Revenue | -60.3% | 156.3% |
| Capex IntensityCapex / Revenue | 0.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-51.4M | $74.6M | ||
| Q3 25 | $-53.5M | $47.6M | ||
| Q2 25 | $-19.9M | $-15.1M | ||
| Q1 25 | $-30.2M | $20.0M | ||
| Q4 24 | $-50.7M | $15.2M | ||
| Q3 24 | $-4.9M | $9.9M | ||
| Q2 24 | $-30.2M | $33.5M | ||
| Q1 24 | $-15.5M | $45.0M |
| Q4 25 | $-52.2M | $74.6M | ||
| Q3 25 | — | $47.6M | ||
| Q2 25 | $-20.0M | $-15.1M | ||
| Q1 25 | $-31.0M | $19.9M | ||
| Q4 24 | $-58.2M | — | ||
| Q3 24 | $-9.4M | $9.9M | ||
| Q2 24 | $-31.2M | $33.4M | ||
| Q1 24 | $-15.7M | $44.9M |
| Q4 25 | -60.3% | 156.3% | ||
| Q3 25 | — | 39.0% | ||
| Q2 25 | -37.6% | -17.7% | ||
| Q1 25 | -53.4% | 48.4% | ||
| Q4 24 | -125.7% | — | ||
| Q3 24 | -18.2% | 10.8% | ||
| Q2 24 | -63.2% | 35.4% | ||
| Q1 24 | -30.9% | 60.0% |
| Q4 25 | 0.9% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 16.3% | 0.0% | ||
| Q3 24 | 8.7% | 0.0% | ||
| Q2 24 | 2.2% | 0.1% | ||
| Q1 24 | 0.4% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | -15.80× | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.52× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALTI
| Management Advisory Fees | $51.1M | 59% |
| Other | $32.7M | 38% |
| Distributions From Investments | $2.9M | 3% |
IRWD
Segment breakdown not available.
